The TEAM-HF Costing Tool integrates sound economic principles to guide users in generating comprehensive cost estimates that could be useful in setting payment rates, contract negotiations, forecasting costs with program expansion or contraction, and identifying ways to improve the efficiency of existing patient-centered programs. Cost estimates can also be used in analyses to evaluate the cost-effectiveness of a given program.
The TEAM-HF Costing Tool was designed as a flexible tool that can be used to generate cost estimates for a variety of patient-centered interventions like disease management programs. In addition to heart failure programs, the TEAM-HF Costing Tool can be applied to estimate the cost of a program targeting patients with COPD, diabetes, or other conditions. The tool assists users in the identification and costing of resources involved directly or indirectly in the delivery of patient-centered programs including personnel, facilities, equipment, supplies, patient incentives, miscellaneous items, and start-up costs. It can also incorporate revenues which allows one to evaluate net profits or losses associated.
The costing tool allows users to select different approaches to estimating costs for personnel and facilities. The costing tool integrates a standardized set of unit costs to improve comparability of cost estimates across programs. The tool also allows users to apply customized unit costs for local decision making. The tool presents results using both standardized and customized unit costs for side-by-side comparisons. The TEAM-HF Costing generates estimates of total program costs, per patient costs, and weekly costs.
Questions about the TEAM-HF tools can be directed to email@example.com.
Cost Effectiveness Model
The TEAM-HF Cost Effectiveness Model is a user-friendly, web-based disease simulation model that allows users to specify characteristics of their patient cohort(s), study design, disease management program, unit costs and apply other options (e.g. discount rates, time horizons) relevant to conducting cost-effectiveness analyses.
- Reed SD, Neilson MP, Gardner M, Li Y, Briggs AH, Polsky DE, Graham FL, Bowers MT, Paul SC, Granger BB, Schulman KA, Whellan DJ, Riegel BJ, Levy WC. TEAM-HF Cost-Effectiveness Model: A Web-Based Program Designed to Evaluate the Cost-Effectiveness of Disease Management Programs in Heart Failure. Am Heart J. 2015;170(5):951-60. PMC4638158
- Reed SD, Li Y, Kamble S, Graham F, Bowers MT, Paul S, Whellan DJ, Riegel B. Introduction of the TEAM-HF Costing Tool: A User-Friendly Spreadsheet Program to Estimate Costs of Providing Patient-Centered Interventions. Circ Cardiovasc Qual Outcomes. 2012;5(1):113-9. PMC3261318
- Li Y, Neilson MP, Whellan DJ, Schulman KA, Levy WC, Reed SD. Associations Between Seattle Heart Failure Model Scores and Health Utilities: Findings From HF-ACTION. J. Card Fail. 2013 May;19(5):311-6. PMC3709866
- Reed SD, Li Y, Dunlap ME, Kraus WE, Samsa GP, Schulman KA, Zile MR, Whellan DJ. Inpatient Resource Use and Medical Costs in the Last Year of Life by Mode of Death in HF-ACTION. Am J Cardiol. 2012;110(8):1150-1155. PMC3462294
- Reed SD, Li Y, Kamble S, Polsky DE, Graham FL, Bowers MT, Paul S, Whellan DJ, Riegel B. Development of a User-Friendly Cost Estimation Tool for Heart Failure Patient-Centered Interventions: The TEAM-HF Costing Tool. 7th Annual Heart Failure Nursing Conference. American Association of Heart Failure Nurses. Seattle WA., June 2011.
- Reed SD, Li Y, Ellis SJ, Whellan DJ, Schulman KA, O'Connor CM, Levy WC. Seattle Heart Failure Model Scores Significantly Predict Medical Resource Use and Costs in HF-ACTION. 15th Annual Scientific meeting of the Heart Failure Society of America. Boston, Mass. Sept. 2011.
- Li Y, Whellan DJ, Dunlap ME, Kraus WE, Samsa G, Schulman KA,Zile M, Reed SD. Resource Use and Medical Costs by Cause of Death in HF-ACTION. 15th Annual Scientific meeting of the Heart Failure Society of America. Boston, Mass. September 2011.
- Dardas TF, Li Y, Reed SD, Whellan DJ, Schulman KA, Kraus WE, O'Connor CM, Ellis SJ, Levy WC. Diagnostic accuracy of the Seattle Heart Failure Model in combination with peak oxygen consumption and VE/VCO2 slope. American Heart Association. Scientific Sessions 2011. Orlando, Fla. November 2011.
- Levy WC, Li Y, Zile M, Ramin S, Dardas T, Whellan D, Schulman K, Ellis S, Neilson M, O'Connor CM and Reed S. Can the Seattle Proportional Risk Model identify patients with a greater ICD benefit in HF-ACTION? 16th Annual Scientific Meeting Heart Failure Society of America. Seattle WA. Sept. 2012.
- Li Y, Neilson M, Whellan DJ, Schulman KA, Levy WC, Reed SD. Seattle Heart Failure Model Scores are Significantly Predictive of Health Utilities and Their Change over Time. 16th Annual Scientific Meeting Heart Failure Society of America. Seattle WA. Sept. 2012.
- Neilson M, Briggs AH, Levy WC, Reed SD. An algorithm for stochastically simulating the cause of death in heart failure patients. 34th Annual Meeting of the Society for Medical Decision Making. Phoenix, Ariz. October 18, 2012.
Duke University Investigators
University of Glasgow Investigators
Andrew Briggs, ScD
Matthew Neilson, PhD
University of Washington Investigators
Wayne Levy, MD
Daniel Polsky, PhD
University of Pennsylvania School of Medicine
Sara Paul, DNP
Western Piedmont Heart Centers
David J. Whellan, MD, MHS
Jefferson Medical College, Thomas Jefferson University
Barbara J. Riegel, DNSc
University of Pennsylvania School of Nursing